ABSORBINE ANALGESIC CREAM
Natural health product licensed in Canada
- Licence holder
- W.F. Young Inc.
- NPN or DIN-HM
- 00641685
- Status
- Active licence
- Licence date
- 7 December 2007
- Revision date
- Not provided
- Form
- Crème
- Route of administration
- Topique
- Application type
- DIN de transition
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| Menthol Source : Mentha arvensis, feuilles | 6 % (p/p) |
| Essence d'Eucalyptus Source : Feuille(s) | 2 % (p/p) |
Non-medicinal ingredients
Stéarate de glycéryle, Alcool cétylique, Myristate d'isopropyle, Eau, Poly(sorbate) 80
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Enfants | Not specified | Not specified | minimum: 3 Tous les jours ; maximum: 4 Tous les jours |
| Adultes | Not specified | Not specified | minimum: 3 Tous les jours ; maximum: 4 Tous les jours |
Uses authorised in Canada
For the temporary relief of minor aches and pains of muscles and joints associated with arthritis , strains, bruises, sprains and simple backache.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
If condition worsens, or if symptoms persist for more than 7 days, discontinue use or consult physician. Do not use if you are allergic to salicylates or if you are taking anticoagulant medications e.g. warfarin. Keep out of childrens reach. Do not use external heat such as a heating pad. avoid contact with mucous membranes and eyes. Do not bandage, or apply to broken skin or wounds.
Source
Official Health Canada record, licence 00641685
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.